Human Phenotype Project Study Protocol

ConditionAdult Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWeizmann Institute of Science

About this trial

This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis.

The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Ages 18+, males and females.

Disqualifiers

Pregnancy.

Mentally disabled or in general legally non-competent.

Prisoner or soldier. Soldiers: mandatory service only

Active cancer

Trial population

General volunteering population who can freely register for the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Adult disease

Development of medical conditions based on participant's self-reporting coded to ICD11.

Time frame
25 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.